To prove that the effect is characteristic for cancer cells, complementary experiments with normal cells (Hs5) were performed in which the viability, proliferation, and cell cycle as well as the expression of proliferating cell nuclear antigen (PCNA) and Ki-67 genes were assessed. This evidence concerns the gene PCNA and cancer.